You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

avelumab

Showing 26 - 50 of 171
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Helsinki (TILT-123, Avelumab)

Recruiting
  • Melanoma
  • Head and Neck Squamous Cell Carcinoma
  • TILT-123
  • Avelumab
  • Helsinki, Finland
    Docrates Cancer Center
Jul 12, 2022

Urothelial Carcinoma Trial (Avelumab)

Not yet recruiting
  • Urothelial Carcinoma
  • Avelumab
  • (no location specified)
Oct 26, 2022

Stage III Merkel Cell Carcinoma AJCC v8, Stage IIIB Merkel Cell Carcinoma AJCC v8, Stage IIIA Merkel Cell Carcinoma AJCC v8

Recruiting
  • Stage III Merkel Cell Carcinoma AJCC v8
  • +2 more
  • Avelumab
  • +2 more
  • Orange, California
  • +10 more
Jan 30, 2023

CNS Tumors Trial in Worldwide (Avelumab, Lenvatinib)

Recruiting
  • Central Nervous System Tumors
  • Saint Louis, Missouri
  • +9 more
Jul 21, 2022

Head and Neck Squamous Cell Carcinoma Trial in La Jolla (Avelumab, Palbociclib, Cetuximab)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Avelumab
  • +2 more
  • La Jolla, California
    UC San Diego Moores Cancer Center
Feb 16, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Gyeonggi-do, Seoul (GEN-001, Avelumab)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Gyeonggi-do, Korea, Republic of
  • +4 more
Jun 14, 2022

Solid Tumor, Non Small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck Trial in New Haven, Atlanta, Portland

Recruiting
  • Solid Tumor
  • +3 more
  • New Haven, Connecticut
  • +2 more
Aug 1, 2022

Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)

Recruiting
  • Triple Negative Breast Cancer
  • +5 more
  • Manchester, Greater Manchester, United Kingdom
  • +6 more
Jan 5, 2023

SOGUG-AVELUMAB_RWD

Recruiting
  • Metastatic Urothelial Carcinoma
  • Avelumab
  • Vigo, Pontevedra, Spain
  • +21 more
Jan 17, 2023

Clear-cell Renal Cell Carcinoma, RCC, Kidney Cancer Trial in Birmingham (Avelumab, Sunitinib)

Withdrawn
  • Clear-cell Renal Cell Carcinoma
  • +3 more
  • Birmingham, Alabama
    University of Alabama Hematology Oncology Clinic at Medical West
Feb 14, 2022

Glioblastoma, GBM Trial in New York (Avelumab, MRI-guided LITT therapy)

Completed
  • Glioblastoma
  • GBM
  • Avelumab
  • MRI-guided LITT therapy
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Dec 31, 2021

Penile Cancer, Penile Tumors, Penile Squamous Cell Carcinoma Trial in Besançon (Avelumab)

Recruiting
  • Penile Cancer
  • +2 more
  • Avelumab
  • Besançon, France
    Antoine THIERY VUILLEMIN
Feb 23, 2022

Breast Cancer Trial in United States (Avelumab, Endocrine therapy, Palbociclib)

Recruiting
  • Breast Cancer
  • Avelumab
  • +2 more
  • Birmingham, Alabama
  • +3 more
Apr 15, 2022

Metastatic Colorectal Cancer Trial in Italy (Cetuximab, Avelumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Ancona, Italy
  • +23 more
Oct 25, 2022

Non Small Cell Lung Cancer Trial in Nijmegen (89Zr-avelumab PET, Avelumab)

Completed
  • Non Small Cell Lung Cancer
  • 89Zr-avelumab PET
  • Avelumab
  • Nijmegen, Netherlands
    Radboud University
Jan 6, 2022

Learn About First-line Avelumab Maintenance in Japanese Locally

Not yet recruiting
  • Urothelial Carcinoma
  • Avelumab
  • Nagoya, Aichi, Japan
  • +14 more
Jul 21, 2022

Bladder Carcinoma Trial in France (Avelumab, GC)

Terminated
  • Bladder Carcinoma
  • Besançon, France
  • +12 more
Apr 26, 2022

Malignant Mesothelioma (MPM) Trial in United States (Avelumab, Stereotactic Body Radiation Therapy)

Active, not recruiting
  • Malignant Mesothelioma (MPM)
  • Avelumab
  • Stereotactic Body Radiation Therapy
  • Basking Ridge, New Jersey
  • +6 more
Mar 7, 2022

Penile Cancer, Advanced Cancer, Metastatic Cancer Trial in Toronto (Avelumab, Best Supportive Care)

Recruiting
  • Penile Cancer
  • +2 more
  • Avelumab
  • Best Supportive Care
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Nov 26, 2021

Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Locally Advanced Merkel Cell

Not yet recruiting
  • Clinical Stage III Merkel Cell Carcinoma AJCC v8
  • +5 more
  • Avelumab
  • +6 more
  • (no location specified)
Jul 13, 2023

Cancer Trial in Germany (Avelumab)

Completed
  • Cancer
  • Avelumab
  • Halle (Saale), Germany
  • +3 more
Feb 24, 2022

Small Cell Lung Carcinoma Trial in Greece (Avelumab)

Active, not recruiting
  • Small Cell Lung Carcinoma
  • Avelumab
  • Chaïdári, Athens, Greece
  • +5 more
Apr 18, 2022

Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)

Terminated
Has Results
  • Merkel Cell Polyomavirus Infection
  • Stage IV Merkel Cell Carcinoma AJCC v7
  • Avelumab
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 25, 2022

T-Cell Lymphoma Relapsed, T-Cell Lymphoma Refractory Trial in London (Avelumab)

Completed
  • T-Cell Lymphoma Relapsed
  • T-Cell Lymphoma Refractory
  • Avelumab
  • London, United Kingdom
    University College London Hospital
Oct 1, 2021

Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma With Glandular

Recruiting
  • Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2021